Page last updated: 2024-10-25

ciprofloxacin and Dermatitis, Atopic

ciprofloxacin has been researched along with Dermatitis, Atopic in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaminski, MM1
Sauer, SW1
Klemke, CD1
Süss, D1
Okun, JG1
Krammer, PH1
Gülow, K1

Other Studies

1 other study available for ciprofloxacin and Dermatitis, Atopic

ArticleYear
Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression.
    Journal of immunology (Baltimore, Md. : 1950), 2010, May-01, Volume: 184, Issue:9

    Topics: Cells, Cultured; Ciprofloxacin; Dermatitis, Atopic; DNA, Mitochondrial; Electron Transport Complex I

2010